The Biden Administration made the controversial decision to support waiving certain IP protections for COVID-19 related drugs and products. AAF Analyst Tom Lee and Director of Health Care Policy Christopher Holt join us to discuss their latest insight into this shift.

Apple: podcasts.apple.com/us/podcast/the-…st/id1462191777 Spotify: open.spotify.com/show/7aWwYw3EKPmTqLQMbRGR2e